Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker

Journal of Human Hypertension

Volumn 28, Issue 10, 2014, Pages 606-609

  Gavriilaki, E ^a   Gkaliagkousi, E ^a   Nikolaidou, B ^a   Triantafyllou, G ^a   Chatzopoulou, F ^b   Douma, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; TRIACYLGLYCEROL; VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; PEPTIDE HYDROLASE;

ADULT; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; MALE; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; TREADMILL EXERCISE; TREATMENT RESPONSE; BLOOD; DRUG EFFECTS; FIBRINOLYSIS; HYPERTENSION;

ADULT; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTITHROMBIN III; EXERCISE; FEMALE; FIBRINOLYSIS; HUMANS; HYPERTENSION; MALE; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSIS;

EID: 84926208422     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.18     Document Type: Article

References (17)

1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219.
2. Trifiletti A, Barbera N, Pizzoleo MA, Lasco A, Lucifora S, Leone G et al. Haemostatic variables in arterial hypertension. Haemostasis 1995; 25(5): 237-240.
3. Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88(2): 99-107.
4. Yang P, Liu YF, Yang L, Wei Q, Zeng H. Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension. Clin Cardiol 2010; 33(6): E81-E86.
5. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006; 26(12): 2793-2799.
6. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3(8): 1879-1883.
7. Papadopoulos D, Mourouzis I, Kotrotsou A, Papazachou U, Sanidas E, Tsioufis K et al. Hemostasis parameters disturbances in healthy individuals with prehypertension. Clin Exp Hypertens 2012; 34(6): 385-388.
8. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49(3): 432-438.
9. von Kanel R, Hong S, Pung MA, Mills PJ. Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise. Am J Hypertens 2007; 20(6): 670-675.
10. Lekakis J, Triantafyllidi H, Galea V, Koutroumbi M, Theodoridis T, Komporozos C et al. The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension. J Thromb Thrombolysis 2008; 25(2): 179-184.
11. DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF. Fibrinolytic responses to acute physical activity in older hypertensive men. J Appl Physiol (1985) 1997; 82(6): 1765-1770.
12. Liakos CI, Vyssoulis GP, Michaelides AP, Chatzistamatiou EI, Theodosiades G, Toutouza MG et al. The effects of angiotensin receptor blockers vs calcium channel blockers on the acute exercise-induced inflammatory and thrombotic response. Hypertens Res 2012; 35(12): 1193-1200.
13. Gkaliagkousi E, Gavriilaki E, Yiannaki E, Markala D, Papadopoulos N, Triantafyllou A et al. Platelet activation in essential hypertension during exercise: pre-and posttreatment changes with an angiotensin II receptor blocker. Am J Hypertens (e-pub ahead of print 23 August 2013).
14. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF et al. ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997; 96(1): 345-354.
15. Szymanski LM, Pate RR. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men. Med Sci Sports Exerc 1994; 26(9): 1102-1108.
16. Galea V, Triantafyllidi H, Theodoridis T, Koutroumbi M, Christopoulou-Cokkinou V, Kremastinos D et al. Long-term treatment with ramipril favourably modifies the haemostatic response to acute submaximal exercise in hypertensives. J Renin Angiotensin Aldosterone Syst 2012; 14: 322-329.
17. Liakos CI, Michaelides AP, Vyssoulis GP, Chatzistamatiou EI, Dilaveris PE, Markou MI et al. The antihypertensive treatment effect on left ventricular diastolic function is reflected in exercise electrocardiogram. J Electrocardiol 2012; 45(1): 28-35.